Can rectal NSAIDs prevent post-ERCP pancreatitis?

被引：0
|
作者：
Pier Alberto Testoni
机构：
[1] San Raffaele Scientific Institute,Vita
来源：
Nature Reviews Gastroenterology & Hepatology | 2012年 / 9卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Acute pancreatitis is the most common and feared complication following endoscopic retrograde cholangiopancreatography (ERCP). Pharmacological prevention of post-ERCP pancreatitis has been disappointing, especially in high-risk patients. However, a prospective multicentre trial has demonstrated the efficacy of rectal administration of indomethacin for preventing post-ERCP pancreatitis in high-risk cases.
引用
收藏
页码：429 / 430
页数：1
相关论文
共 50 条
  • [1] Can rectal NSAIDs prevent post-ERCP pancreatitis?
    Testoni, Pier Alberto
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2012, 9 (08) : 429 - 430
  • [2] Role of rectal nsaids in the prevention of post-ERCP pancreatitis
    Alabd, Mohammedomer
    Abdo, Abdelmunemeltayeib
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 495 - 496
  • [3] Rectal Indomethacin to Prevent Post-ERCP Pancreatitis
    Akhter, Ahmed
    Pfau, Patrick R.
    Gopal, Deepak V.
    GASTROENTEROLOGY, 2016, 151 (03) : 568 - 569
  • [4] Can octreotide prevent post-ERCP pancreatitis?
    Kaya, Ekrem
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (07): : 1540 - 1541
  • [5] Rectal Indomethacin to Prevent Post-ERCP Pancreatitis REPLY
    Elmunzer, B. Joseph
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (03): : 278 - 279
  • [6] Rectal Indomethacin to Prevent Post-ERCP Pancreatitis Reply
    Levenick, John M.
    GASTROENTEROLOGY, 2016, 151 (03) : 569 - 570
  • [7] A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis
    Elmunzer, B. J.
    Waljee, A. K.
    Elta, G. H.
    Taylor, J. R.
    Fehmi, S. M. A.
    Higgins, P. D. R.
    GUT, 2008, 57 (09) : 1262 - 1267
  • [8] Rectal NSAIDs for Post-ERCP Pancreatitis Prevention: A Meta-Analysis
    Sawas, Tarek
    Al Halabi, Shadi
    Al-Kawas, Firas
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S60 - S61
  • [9] WHY IS THE RECTAL ROUTE FOR NSAIDS FAVORABLE FOR PREVENTING POST-ERCP PANCREATITIS?
    Swaminathan, Gayathri
    Tsai, Cheng-Yu
    Yu, Mang
    Barakat, Monique T.
    Frymoyer, Adam R.
    Husain, Sohail Z.
    GASTROENTEROLOGY, 2024, 166 (05) : S759 - S759
  • [10] Benefits of NSAIDs Plus Pancreatic Stenting to Prevent Post-ERCP Pancreatitis
    Hanscom, Mark
    GASTROENTEROLOGY, 2024, 167 (04) : 812 - 812
12345